Interestingly, it has been suggested that interferon-induced immune activation on depression may be explained in part by alterations in neurotrophin signaling capacity, reflected by decreases in serum BDNF following interferon treatment [74]. This evidence concerns the gene BDNF and depressive symptom measurement.